Defeat DIPG Makes Grant to Oncoceutics to Support Development of ONC201
Michael Mosier Defeat DIPG Foundation has made a grant to support development of ONC201, an experimental drug currently being tested to treat DIPG. We have made this grant in collaboration with the Musella Foundation, The Cure Starts Now, Cancer Commons, and xCures. Our objective in funding this program is to increase the availability of ONC201 […]